CClinicalTrials.gg
CompletedNCT06908811IOVUpdated Apr 3, 2025

Effect of a Novel Blend of Plant Protein and Additional Ingredients on Resistance Training Adaptations

An interventional study of Novel Plant Protein Blend and Pea/Rice Protein Blend in Resistance Exercise, sponsored by Lindenwood University. Completed at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-03.

Sponsored by Lindenwood University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Aug 2022, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

This study seeks to compare the observed changes in resistance training adaptations (strength, performance, body composition, recovery, and lactate responses) after supplementation of isocaloric and isonitrogenous amounts of a novel plant protein formulation against changes observed in a pea/rice plant protein blend, whey protein, and a carbohydrate placebo in healthy resistance-trained men and women between the ages of 18-39.

Read the detailed description

This study seeks to compare the observed changes in resistance training adaptations (strength, performance, body composition, recovery, and lactate responses) after supplementation of isocaloric and isonitrogenous amounts of a novel plant protein formulation against changes observed in a pea/rice plant protein blend, whey protein, and a carbohydrate placebo in healthy resistance-trained men and women between the ages of 18-39.

02

Conditions studied

  • Resistance Exercise
03

In context

Lead sponsor

Lindenwood University is the lead sponsor of 29 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Between the ages of 18-39 years
  • Participants will be healthy and free of disease as determined by evaluation of a medical history
  • All participants will be required to abstain from taking any additional forms of nutritional supplementation deemed to be ergogenic or that will impact resistance training adaptations (pre-workouts, creatine, beta-alanine, etc.) for four weeks prior to beginning this study and for the entire duration of the study.

Exclusion criteria

Exclusion Criteria

  • Those individuals less than 18 and greater than 39 years of age will be excluded.
  • Participants who are determined to not be weight stable defined as pre-study and visit 1 body mass levels deviating by 3% or more.
  • Any individual who is currently being treated for or diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, psychiatric, hematological, neurological or endocrinological disorder or disease.
  • Body mass index >29.9 kg/m2. Males with a body mass index greater than 29.9 kg/m2, but a body fat percentage less than 27.5% fat will be accepted into the study. Females with a body mass index greater than 29.9 kg/m2, but a body fat percentage less than 32.5% fat will be accepted into the study. The average body mass index for the entire study cohort will be less than 27.5 kg/m2. As such, an ongoing calculation of the recruited cohort's mean body mass index will be maintained and people will only be randomized into the study if the average cohort body mass index value does not exceed 27.5 kg/m2
  • Individuals who present with any previous injury or illness that would prevent them from appropriately completing all exercise lifts.
  • Participants who are not able to fit onto the DEXA table will not be able to participate in the research due to size restrictions of the equipment. This typically includes individuals exceeding 400 pounds or those greater than 6'4".
  • Those individuals with less than 3 months of structured resistance training, aerobic training, or team sport participation experience will be excluded from the study.
  • Pregnant women, women trying to become pregnant, or nursing women. Currently participating in another research study with an investigational product or have been in another research study in the past 30 days.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Novel Plant Protein

    Novel plant protein blend containing 30 grams of protein taken twice per day for 8 weeks

    Dietary Supplement: Novel Plant Protein Blend

  • Active comparator
    Pea/Rice Protein

    Pea/Rice protein blend containing 30 grams of protein taken twice per day for 8 weeks

    Dietary Supplement: Pea/Rice Protein Blend

  • Active comparator
    Whey Protein

    Whey protein blend containing 30 grams of protein taken twice per day for 8 weeks

    Dietary Supplement: Whey Protein

  • Placebo comparator
    Carbohydrate Placebo

    Carbohydrate placebo (maltodextrin) taken twice per day for 8 weeks

    Dietary Supplement: Carbohydrate Placebo

Interventions

  • Dietary supplementNovel Plant Protein Blend

    Novel plant protein blend containing 30 grams of protein.

  • Dietary supplementPea/Rice Protein Blend

    Pea/Rice protein blend containing 30 grams of protein

  • Dietary supplementWhey Protein

    Whey concentrate protein blend containing 30 grams of protein

  • Dietary supplementCarbohydrate Placebo

    Maltodextrin placebo

06

What researchers measure

Primary outcomes

  1. Change in 4-Compartment Lean Mass

    Lean mass will be assessed using a 4-compartment model, which includes measurements of body density, total body water, and bone mineral content.

    Time frame: Week 0, Week 4, and Week 8

  2. Change in Perceptual Indicators of Training State

    Participants will rate their readiness to train, soreness, recovery, energy, and sleep quality using 100-mm visual analog scales. Each scale is anchored with contextually appropriate statements such as "Lowest Possible" and "Highest Possible."

    Time frame: Week 0, Week 4, and Week 8

  3. Change in Profile of Mood States (POMS) Score

    Mood state will be assessed using the Profile of Mood States (POMS) questionnaire, a validated tool for measuring transient affective states. The POMS consists of six subscales (Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment), with a Total Mood Disturbance (TMD) score calculated by summing negative subscale scores and subtracting the Vigor score. Higher TMD scores indicate greater mood disturbance, while lower scores indicate improved mood state.

    Time frame: Week 0, Week 4, and Week 8

  4. Change in Pressure to Pain Threshold

    Pressure pain threshold will be assessed using a digital algometer to determine the minimum pressure required to elicit pain. Higher scores indicate higher tolerance to pain.

    Time frame: Week 0, Week 4, and Week 8

  5. Change in Handgrip Strength

    Maximal handgrip strength will be assessed using a calibrated hand dynamometer. Higher values indicate greater strength.

    Time frame: Week 0, Week 4, and Week 8

  6. Change in Isometric Mid-Thigh Pull Force

    Maximal force output will be assessed using an isometric mid-thigh pull on a force plate, measured in Newtons. Higher scores equal greater force production

    Time frame: Week 0, Week 4, and Week 8

  7. Change in Hex Bar Deadlift One-Repetition Maximum (1RM)

    Maximal hex bar deadlift strength will be assessed using a standardized one-repetition maximum (1RM) test.

    Time frame: Week 0, Week 4, and Week 8

  8. Change in Bench Press One-Repetition Maximum (1RM

    Maximal upper-body strength will be assessed using a standardized one-repetition maximum (1RM) bench press test.

    Time frame: Week 0, Week 4, and Week 8

  9. Change in Isokinetic Peak Knee Extension Torque

    Peak torque of the quadriceps will be assessed using an isokinetic dynamometer. Higher values indicate greater knee extensor strength.

    Time frame: Week 0, Week 4, and Week 8

  10. Performance in 5 Sets of Hex Bar Deadlift Protocol

    Strength endurance will be assessed using a hex bar deadlift protocol consisting of 3 sets of 10 repetitions at 70% 1RM and 2 sets to failure at 80% 1RM. Repetition count and total volume lifted will be recorded.

    Time frame: Week 0, Week 4, and Week 8

Secondary outcomes

  1. Change in 4-Compartment Fat Mass

    Fat mass will be measured using a 4-compartment model, which integrates body density, total body water, and bone mineral content.

    Time frame: Week 0, Week 4, and Week 8

  2. Change in 4-Compartment Fat-Free Mass

    Fat-free mass will be assessed using a 4-compartment model, providing a more precise measurement of body composition changes.

    Time frame: Week 0, Week 4, and Week 8

  3. Change in 4-Compartment Percent Body Fat

    Body fat percentage will be assessed using a 4-compartment model.

    Time frame: Week 0, Week 4, and Week 8

  4. Change in Total, Extracellular, and Intracellular Body Water

    Hydration status will be measured using bioelectrical impedance analysis (BIA) to assess total, extracellular, and intracellular body water content.

    Time frame: Week 0, Week 4, and Week 8

  5. Change in Dry Fat-Free Mass

    Dry fat-free mass will be assessed using a combination of dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) for a comprehensive measure of lean tissue mass.

    Time frame: Week 0, Week 4, and Week 8

07

Study locations

1 site
  • Exercise and Performance Nutrition Laboratory
    St. Charles, Missouri 63301, United States
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06908811
Lead sponsor
Lindenwood University
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Aug 19, 2022
Primary completion
Jan 17, 2025
Completion
Jan 17, 2025
Last update
Apr 3, 2025

Study contacts

Chad Kerksick, PhD
principal investigator · Lindenwood University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion